Mathias Vormehr PhD

Dr. Mathias Vormehr is an immunologist heading the research group Cancer Vaccines at BioNTech RNA Pharmaceuticals GmbH (Mainz, Germany). He holds a diploma in biomedical chemistry and a doctorate in pharmacy from the University of Mainz. His work on neoantigens and personalized cancer vaccines was published in high impact journals including Nature. Currently his research focuses on the clinical translation of cancer vaccines and the testing of suitable combination partners.